• Edgewise Therapeutics Chief Scientific Officer Alan J. Russell exercised stock options for 200,000 shares on July 1, 2026 at USD 0.18 to USD 0.45.
• Russell sold 200,000 shares the same day at an average price of about USD 39.41.
• His direct holdings fell to 24,555 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001853529-26-000001), on July 02, 2026, and is solely responsible for the information contained therein.